THE SHARE: Change: -0.02 SEK (-4.57%) / Price: 0.33 SEK / Sep 28, 2023, 11:45 am (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

MAR

  • 1 Jun, 2022
    Spago Nanomedical carries out a rights issue of up to SEK 61.8 M
  • 1 Jun, 2022
    Spago Nanomedical genomför en företrädesemission om upp till 61,8 MSEK
  • 19 Apr, 2022
    Extended SpagoPix patent protection in Japan
  • 19 Apr, 2022
    Förlängt patentskydd för SpagoPix i Japan
  • 13 Jan, 2022
    Spago Nanomedicals phase 1 study with SpagoPix shows clear contrast enhancement and is expanded into new indications
  • 13 Jan, 2022
    Spago Nanomedicals fas 1-studie med SpagoPix visar tydlig kontrast och utökas till nya indikationer
  • 6 Dec, 2021
    Tumorad® shows good safety in preclinical studies
  • 6 Dec, 2021
    Tumorad® visar god säkerhet i prekliniska studier
  • 2 Dec, 2021
    Second dose group fully recruited in Spago Nanomedical’s phase 1 study with SpagoPix
  • 2 Dec, 2021
    Andra dosgruppen färdigrekyterad i Spago Nanomedicals fas 1-studie med SpagoPix
  • 1
  • 2
  • 3
  • …
  • 8
  • Next
Back

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2023 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications